The Nociceptive Interferonopathy Hypothesis: Does mtDNA Leakage in Senescent TRPV1+ Neurons Calibrate the Human Biological Clock?

My recent work has centered on the CST complex and telomeric stability, but the correlation between pain sensitivity and biological age suggests we should look away from the nucleus and toward the periphery. We know chronic pain correlates with accelerated GrimAge (β=1.46 years, P<0.001), yet the causality is usually dismissed as a vague side effect of "stress."

I'm proposing a more concrete mechanistic link: The Nociceptive Interferonopathy Hypothesis. My premise is that an individual's pain threshold isn't just a psychological trait; it's a direct readout of steady-state cGAS-STING activation within the dorsal root ganglia (DRG), driven by mitochondrial DNA (mtDNA) leakage in senescent nociceptors.

The Mechanism: From Senescence to Systemic Alarm

Evidence shows that neuronal senescence in Trpv1+ nociceptors, identified by p16 and IL-6 expression, is a primary driver of chronic pain. I suspect the actual "clock" at work is the loss of mitochondrial integrity in these cells. Senescent cells suffer from profound mitochondrial dysfunction. In post-mitotic neurons like those in the DRG, mtDNA leaking into the cytosol triggers the cGAS-STING pathway, creating a localized, chronic Type I interferon response. Since nociceptors function as high-gain amplifiers for internal signals, this "nociceptive interferonopathy" lowers the mechanical and thermal firing threshold of the neuron. This explains why experimental pain sensitivity tracks so closely with epigenetic age acceleration. A body that hurts more is often a body where intracellular alarms are permanently stuck "on" at the sensory level.

Why Pain Thresholds Beat Blood Panels

Standard blood panels measure systemic cytokines like IL-6 or TNF-α, but these are notoriously volatile—they change based on your last workout, your diet, or your sleep schedule. A pain threshold, however, provides a cumulative, integrated readout of neuroinflammation and glial activation. Furthermore, nociceptive senescence likely initiates a self-reinforcing loop: increased nociceptive signaling inhibits vagal tone. Since the vagus nerve handles the cholinergic anti-inflammatory pathway, this suppression leads to widespread up-regulation of inflammatory pathways. It essentially locks the individual into a state of accelerated systemic decay.

Testing and Falsification

We can test this through longitudinal studies of aging cohorts using three specific methods:

1. Functional Assay: Quantitative Sensory Testing (QST) to map individual pain thresholds.
2. Molecular Proxy: Measuring cGAMP levels in cerebrospinal fluid or using specialized PET tracers to visualize STING activation in the DRG.
3. Intervention: If STING inhibitors or localized senolytics in the DRG restore the pain threshold and subsequently slow the rate of GrimAge acceleration over 12 months, the hypothesis holds.

The theory is falsified if we can decouple pain sensitivity from systemic interferon signatures. For instance, if peripheral nerve blocks that don't change the systemic epigenetic trajectory can completely reset pain sensitivity, then the "Pain Clock" is merely a symptom of aging rather than a driver of it.